Radiotherapy for endometrial cancer.

{"article_title":"Radiotherapy for endometrial cancer.","author":"Chargari C, Peignaux K, Escande A, Renard S, Lafond C, Petit A, Hannoun-L\u00e9vi JM, Durdux C, Haie-M\u00e9der C","journal_title":"Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","issn":"1769-6658","isbn":"","publication_date":"2022-02-01","volume":"26","issue":"1-Feb","first_page":"309","page_count":"","accession_number":"34955423","doi":"10.1016\/j.canrad.2021.11.016","publisher":"Elsevier","doctype":"Journal Article","subjects":"France; Endometrial Neoplasms radiotherapy; Brachytherapy methods; Endometrial Neoplasms pathology; Female; France; Humans; Neoplasm Staging; Postoperative Care; Radiation Oncology; Radiotherapy, Adjuvant methods; Tumor Burden","interest_area":["Obstetrics & Gynecology"," Oncology"," Radiology"],"abstract":"The first intent upfront treatment of endometrial cancer is surgery. External radiotherapy and brachytherapy; however, are important tools in adjuvant setting, according to histopathological risk factors for locoregional recurrence or in the event of an inoperable tumor. We present the update of the recommendations of the French society of oncological radiotherapy on the indications and technical methods of performing radiotherapy and brachytherapy for endometrial cancer. Copyright \u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=34955423","isPdfLink":false,"isSAML":false,"an":"34955423","number_other":"","type_pub":"","issn_electronic":"1769-6658","languages":"English","language":"eng","date_entry":"Date Created: 20211227 Date Completed: 20220217 Latest Revision: 20220217","date_update":"20240104","titleSource":"Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [Cancer Radiother] 2022 Feb-Apr; Vol. 26 (1-2), pp. 309-314. Date of Electronic Publication: 2021 Dec 23.","date_pub_cy":"","type_document":"","contract_publisher":"","authored_on":"2022-02-01","description":"The first intent upfront treatment of endometrial cancer is surgery. External radiotherapy and brachytherapy; however, are important tools in adjuvant setting, according to histopathological risk factors for locoregional recurrence or in the event of an inoperable tumor. We present the update of the recommendations of the French society of oncological radiotherapy on the indications and technical methods of performing radiotherapy and brachytherapy for endometrial cancer.<br \/> (Copyright © 2021 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.)","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&scope=site&db=mdl&AN=34955423&authtype=shib&custid=ns346513&group=main&profile=eds","no_of_pages":"","authored_by":"Chargari C, Peignaux K, Escande A, Renard S, Lafond C, Petit A, Hannoun-L\u00e9vi JM, Durdux C, Haie-M\u00e9der C"}